Editorial: Mass spectrometry-based proteomics in drug discovery and development

被引:1
|
作者
Pejchinovski, Martin [1 ]
Magalhaes, Pedro [2 ]
Metzger, Jochen [3 ]
机构
[1] Thermo Fisher Sci, Dept Analyt Instruments Grp, Germering, Germany
[2] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium
[3] TUV SUD Prod Serv GmbH, Med Hlth Serv, In Vitro Diag, Hamburg, Germany
关键词
mass spectrometry; proteomics; biomarker; clinical application; drug development;
D O I
10.3389/fmed.2024.1448152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Origins of mass spectrometry-based proteomics
    Matthias Mann
    Nature Reviews Molecular Cell Biology, 2016, 17 : 678 - 678
  • [32] Challenges in mass spectrometry-based proteomics
    Reinders, J
    Lewandrowski, U
    Moebius, J
    Wagner, Y
    Sickmann, A
    PROTEOMICS, 2004, 4 (12) : 3686 - 3703
  • [33] Development and application of immobilized surfactant in mass spectrometry-based proteomics
    Wu, Qiong
    Jiao, Fenglong
    Gao, Fangyuan
    Xia, Chaoshuang
    Lv, Yayao
    Yu, Qian
    Zhang, Yangjun
    Qian, Xiaohong
    RSC ADVANCES, 2017, 7 (70): : 44282 - 44288
  • [34] Label-free mass spectrometry-based proteomics for biomarker discovery and validation
    Pham, Thang V.
    Piersma, Sander R.
    Oudgenoeg, Gideon
    Jimenez, Connie R.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (04) : 343 - 359
  • [35] Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
    Wu Jianqiang
    Zhang Jun
    Wei Jing
    Zhao Yuanli
    Gao Youhe
    中华神经外科杂志(英文), 2020, (02) : 82 - 91
  • [36] Discovery and validation of therapeutic targets in immune cells by mass spectrometry-based proteomics
    Au, Yu-Wah
    Satijn, David
    Mehnert, Martin
    Lachaud, Amaury
    Feng, Yuehan
    Vowinckel, Jakob
    Bon, Helene
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
    Wu J.
    Zhang J.
    Wei J.
    Zhao Y.
    Gao Y.
    Chinese Neurosurgical Journal, 6 (1)
  • [38] False discovery rates and related statistical concepts in mass spectrometry-based proteomics
    Choi, Hyungwon
    Nesvizhskii, Alexey I.
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (01) : 47 - 50
  • [39] Editorial: Mass spectrometry-based proteogenomics - advances in mutant proteomics and clinical oncology
    Vegvari, Akos
    Nishimura, Toshihide
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS: HEAD-AND-NECK CANCER BIOMARKERS AND DRUG-TARGETS DISCOVERY
    Matta, Ajay
    Ralhan, Ranju
    De Souza, Leroi V.
    Siu, K. W. Michael
    MASS SPECTROMETRY REVIEWS, 2010, 29 (06) : 945 - 961